A Pilot Phase II Trial of Continuous-Infusion Interleukin-2 Followed by Lymphokine-Activated Killer Cell Therapy and Bolus-Infusion Interleukin-2 in Renal Cancer

C. Gambacorti-Passerini, J. A. Hank, M. R. Albertini, A. A. Borchert, K. H. Moore, J. H. Schiller, R. Bechhofer, E. C. Borden, B. Storer, P. M. Sondel